Abgent, Inc Company Profile

00:33 EDT 31st August 2014 | BioPortfolio

Abgent develops powerful tools to profile posttranslational modifications related to cellular function and disease. Abgent antibodies offer the most extensive coverage targeting protein kinases, phosphatases, methyl and acetyl transferases, ubiquitin and SUMO, glycosylases and other protein modification enzymes. Our mission is to accelerate research and discovery by targeting post-translational modifications that dynamically regulate protein function, and to thereby accelerate understanding of the complex path leading from cell signaling to pathology.
Abgent's innovative products and custom services for the study of proteomic modifications rank us as a selected supplier in Natures 2003 Antibody Technology and 2004 Drug Discovery Features and in The Scientist's 2003 Cell Signaling Feature. Our Strengths
Innovation of exclusive products for a broad range of proteomic and life science applications.
A demonstrated commitment to rapid service at competitive prices, with superior quality. Flexible to unique customer requirements.
Modern facilities and equipment for peptide synthesis, antibody development, protein expression/purification, and assay development.
Project status and data reports are monitored by our exclusive in-house custom service database tracking system.
Skilled biotechnology workforce with interdisciplinary expertise.
Collaborations with leading scientists, institutions, and companies

Location

6310 Nancy Ridge Dr., Ste. 106
San Diego
California
92121
United States of America

Contact

Phone: (858) 622-0099
Fax: (858) 622-0609
Email: info@abgent.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Abgent, Inc

Abgent develops powerful tools to profile posttranslational modifications related to cellular function and disease. Abgent antibodies offer the most extensive coverage targeting protein kinases, phosp...

More Information about "Abgent, Inc" on BioPortfolio

We have published hundreds of Abgent, Inc news stories on BioPortfolio along with dozens of Abgent, Inc Clinical Trials and PubMed Articles about Abgent, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abgent, Inc Companies in our database. You can also find out about relevant Abgent, Inc Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record